Vivek Ramaswamy Quotes

I want to make a drug. I want the science to be more than imaginary, where I think, 'We're learning these fundamental principles, blah, blah, blah, blah, blah.' I think we are doing that, but I want to do something really practical. I want to actually, in my lifetime, help people.

The problem we are trying to solve is that of drugs that would have never seen the light of day for reasons that have nothing to do with the inherent properties of drug candidates themselves and more to do with bureaucratic institutions within which they often sit.

To start with, pharma was an industry based on innovation, drug discovery.

There's always going to be the need for new medications, better medications.

Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

I keep encouraging the pharmaceutical companies to put more money into R&D.

Analytical pharmacology has got an important and exciting future.

Drug discovery is terribly expensive, just to find out how one drug could or could not work and all its side effects.

The United States has an active pharmaceutical industry that has brought huge benefits to the U.S. public. Most Americans, who benefit from these advances, have little understanding of how difficult it is to create an important new medical therapy and make it available to improve public health.

All I ever promised was that I was sure I could develop a new pharmacological agent which might answer a physiological question. Any utility would be implicit in that answer.

If we can actually decrease the failure rate from nine out of 10 drugs failing in clinical trials and instead have seven out of 10 instead failing, that is a major victory for drug discovery and for people having better therapy.

When you work in the pharmaceutical industry you realize that there's a lot out of people's control, and there's ways that people can be helped.

I've heard drug experts say they believe if penicillin were discovered today, the FDA wouldn't license it.

If you go to the FDA with a drug that's only meant to treat 50 people, and it's a 95 percent cure rate, you'll get your drug approved.

I'd like to focus on my life on creating new medicines for people who are suffering from rare disease.

Pharmacology is benefited by the prepared mind. You need to know what you are looking for.

Cadila, India's sixth-largest drugmaker by sales, spent $250 million developing Lipaglyn, a new chemical entity or new discovery, and aims to spend another $150 million to $200 million to launch the drug outside India.

Bayer Pharmaceutical Products: Aspirin, Heroin, Lycetrol: Send for Samples and Literature

We should look for ways to expedite generic drug approvals, particularly for products that have a long history of being safe and effective.

I really was inspired by the possibility of more directly being involved in the development of drugs myself.

If we can validate our scientific bets in the clinic, if we can bring valuable new treatments to patients that need them, that will be our ultimate measure of success.

My choice of learning pharmacy was driven by my interests, curiosity, and a desire to seek new medicines for patients.

Fundamental discoveries can and should be made in industry or academies, but to carry that knowledge forward and to develop a new drug to the market has to depend on the resources of industry.

Practically every day, there is a story in the newspapers about a new breakthrough drug on Parkinson's.